254 related articles for article (PubMed ID: 19176375)
1. Proteasome inhibition blocks ligand-induced dynamic processing and internalization of epidermal growth factor receptor via altered receptor ubiquitination and phosphorylation.
Kesarwala AH; Samrakandi MM; Piwnica-Worms D
Cancer Res; 2009 Feb; 69(3):976-83. PubMed ID: 19176375
[TBL] [Abstract][Full Text] [Related]
2. Sulindac metabolites induce proteosomal and lysosomal degradation of the epidermal growth factor receptor.
Pangburn HA; Ahnen DJ; Rice PL
Cancer Prev Res (Phila); 2010 Apr; 3(4):560-72. PubMed ID: 20332299
[TBL] [Abstract][Full Text] [Related]
3. EGF receptor activity modulates apoptosis induced by inhibition of the proteasome of vascular smooth muscle cells.
Ying WZ; Zhang HG; Sanders PW
J Am Soc Nephrol; 2007 Jan; 18(1):131-42. PubMed ID: 17151333
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor (EGF) induces apoptosis in a transfected cell line expressing EGF receptor on its membrane.
Zhao X; Dai W; Zhu H; Zhang Y; Cao L; Ye Q; Lei P; Shen G
Cell Biol Int; 2006 Aug; 30(8):653-8. PubMed ID: 16750403
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor regulates ubiquitination, internalization and proteasome-dependent degradation of connexin43.
Leithe E; Rivedal E
J Cell Sci; 2004 Mar; 117(Pt 7):1211-20. PubMed ID: 14970263
[TBL] [Abstract][Full Text] [Related]
6. Fluorescence resonance energy transfer analysis of proapoptotic CD95-EGF receptor interactions in Huh7 cells.
Eberle A; Reinehr R; Becker S; Häussinger D
Hepatology; 2005 Feb; 41(2):315-26. PubMed ID: 15660394
[TBL] [Abstract][Full Text] [Related]
7. Internalization of EGF receptor following lipid rafts disruption in keratinocytes is delayed and dependent on p38 MAPK activation.
Lambert S; Ameels H; Gniadecki R; Hérin M; Poumay Y
J Cell Physiol; 2008 Dec; 217(3):834-45. PubMed ID: 18727093
[TBL] [Abstract][Full Text] [Related]
8. Altered regulation of EGF receptor signaling following a partial hepatectomy.
Skarpen E; Oksvold MP; Grøsvik H; Widnes C; Huitfeldt HS
J Cell Physiol; 2005 Mar; 202(3):707-16. PubMed ID: 15389569
[TBL] [Abstract][Full Text] [Related]
9. MDA-7/IL-24, a novel tumor suppressor/cytokine is ubiquitinated and regulated by the ubiquitin-proteasome system, and inhibition of MDA-7/IL-24 degradation enhances the antitumor activity.
Gopalan B; Shanker M; Scott A; Branch CD; Chada S; Ramesh R
Cancer Gene Ther; 2008 Jan; 15(1):1-8. PubMed ID: 17828282
[TBL] [Abstract][Full Text] [Related]
10. Dihydrotestosterone interacts with EGFR/MAPK signalling and modulates EGFR levels in androgen receptor-positive LNCaP prostate cancer cells.
Mukherjee B; Mayer D
Int J Oncol; 2008 Sep; 33(3):623-9. PubMed ID: 18695894
[TBL] [Abstract][Full Text] [Related]
11. Proteasome inhibition: mechanism of action.
DeMartino GN
J Natl Compr Canc Netw; 2004 Nov; 2 Suppl 4():S5-9. PubMed ID: 19791423
[TBL] [Abstract][Full Text] [Related]
12. EGF signalling amplification induced by dynamic clustering of EGFR.
Ichinose J; Murata M; Yanagida T; Sako Y
Biochem Biophys Res Commun; 2004 Nov; 324(3):1143-9. PubMed ID: 15485674
[TBL] [Abstract][Full Text] [Related]
13. A FRET-based probe for epidermal growth factor receptor bound non-covalently to a pair of synthetic amphipathic helixes.
Itoh RE; Kurokawa K; Fujioka A; Sharma A; Mayer BJ; Matsuda M
Exp Cell Res; 2005 Jul; 307(1):142-52. PubMed ID: 15922734
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor internalization rate is regulated by negative charges near the SH2 binding site Tyr992.
Holbrook MR; O'Donnell JB; Slakey LL; Gross DJ
Biochemistry; 1999 Jul; 38(29):9348-56. PubMed ID: 10413509
[TBL] [Abstract][Full Text] [Related]
15. Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutations.
Bremm A; Walch A; Fuchs M; Mages J; Duyster J; Keller G; Hermannstädter C; Becker KF; Rauser S; Langer R; von Weyhern CH; Höfler H; Luber B
Cancer Res; 2008 Feb; 68(3):707-14. PubMed ID: 18245470
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of ErbB2 impairs ligand-dependent downregulation of epidermal growth factor receptors via a post-transcriptional mechanism.
Huang G; Chantry A; Epstein RJ
J Cell Biochem; 1999 Jul; 74(1):23-30. PubMed ID: 10381258
[TBL] [Abstract][Full Text] [Related]
17. Development of a quantitative, cell-based, high-content screening assay for epidermal growth factor receptor modulators.
Wang J; Xie X
Acta Pharmacol Sin; 2007 Oct; 28(10):1698-704. PubMed ID: 17883960
[TBL] [Abstract][Full Text] [Related]
18. CD95 tyrosine phosphorylation is required for CD95 oligomerization.
Eberle A; Reinehr R; Becker S; Keitel V; Häussinger D
Apoptosis; 2007 Apr; 12(4):719-29. PubMed ID: 17195092
[TBL] [Abstract][Full Text] [Related]
19. Identification of EGF receptor C-terminal sequences 1005-1017 and di-leucine motif 1010LL1011 as essential in EGF receptor endocytosis.
Wang Q; Zhu F; Wang Z
Exp Cell Res; 2007 Sep; 313(15):3349-63. PubMed ID: 17643422
[TBL] [Abstract][Full Text] [Related]
20. Receptor overexpression or inhibition alters cell surface dynamics of EGF-EGFR interaction: new insights from real-time single molecule analysis.
Yu C; Hale J; Ritchie K; Prasad NK; Irudayaraj J
Biochem Biophys Res Commun; 2009 Jan; 378(3):376-82. PubMed ID: 19014905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
